Emily's Entourage funds research for remaining CF patients
CNBC · RSS · · AI-summarised by FinFlash
Emily's Entourage, a nonprofit founded to accelerate research, is funding work aimed at the roughly 10% of cystic fibrosis patients who cannot use existing breakthrough drugs. Those treatments have transformed outcomes for most people with the disease, but a subset with certain mutations gains no benefit. The organization is backing research to find options for that remaining group, which has seen little progress from the approved therapies.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.